Pharmacogenetics of Solid Tumors: Directed Therapy in Breast, Lung, and Colorectal Cancer: A Paper from the 2008 William Beaumont Hospital Symposium on Molecular Pathology

Genetic variability in drug-metabolizing enzymes and signaling pathways affects chemotherapy-related toxicity and treatment outcome in cancer. In breast and colorectal cancer, polymorphisms in metabolic enzymes involved in tamoxifen and irinotecan therapies has led the U.S. Food and Drug Administrat...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Snozek, Christine L.H., O'Kane, Dennis J., Algeciras-Schimnich, Alicia
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Investigative Pathology 2009
Materias:
Reviews
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2729835/
https://ncbi.nlm.nih.gov/pubmed/19644023
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2353/jmoldx.2009.090003
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares